跳至主要内容
临床试验/CTRI/2021/01/030412
CTRI/2021/01/030412尚未招募未知

Evaluation of Glycemic Index of vidavance

ModiMundipharma Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • BMI <= 22.9 kg/ m2
  • Willingness to consume the test foods
  • no known food allergy or intolerance;
  • no medications known to affect glucose tolerance (excluding oral contraceptives) â?? stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

排除标准

  • a known history of diabetes mellitus or the use of anti-hyperglycaemic drugs or insulin to treat diabetes and related conditions
  • pregnant or lactating women
  • a major medical or surgical event requiring hospitalization within the preceding 3 months;
  • the presence of disease or drug(s) which influence digestion and absorption of nutrients;
  • the use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution).

研究者

发起方
ModiMundipharma Pvt Ltd

相似试验